Key result
A 12-month nurse-led disease management program for heart failure yielded an incremental cost-effectiveness ratio of $17,543 per EuroQol-5D-based QALY compared to usual care.
Why the study?
Does a 12-month nurse-led disease management program improve cost-effectiveness and quality of life in patients with systolic dysfunction?
RCT
randomized
Yes
Does a 12-month nurse-led disease management program improve cost-effectiveness and quality of life in patients with systolic dysfunction?
Effect estimate: ICER $17,543 per EuroQol-5D-based QALY and $15,169 per HUI3-based QALY
A 12-month nurse-led disease management program is a reasonably cost-effective strategy to improve quality of life in patients with heart failure with systolic dysfunction.
No takes yet. Share an insight, caveat, or question.
Supports adoption of nurse-led HF programs; confirms cost-effectiveness in systolic dysfunction.
Hebert et al. (2008) conducted an RCT in Heart failure with systolic dysfunction. Nurse-led disease management vs. Usual care was evaluated on Quality of life (Health Utilities Index Mark 3 and EuroQol-5D) and cost-effectiveness (incremental cost-effectiveness ratio) (ICER $17,543 per EuroQol-5D-based QALY and $15,169 per HUI3-based QALY). A 12-month nurse-led disease management program for heart failure yielded an incremental cost-effectiveness ratio of $17,543 per EuroQol-5D-based QALY compared to usual care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: